Humana Inc.

HUM's RSI of 71.3 signals overbought conditions with the stock trading near recent peaks despite a trailing P/E of 23.6—elevated compared to historical healthcare insurance averages. The 5.13% short interest remains modest, limiting squeeze potential, while the $23.1B market cap reflects a mid-tier player in managed care. Current valuation paired with stretched momentum indicators suggests limited margin of safety for new entries, though the setup lacks the extreme froth that typically precedes sharp reversals. Execution and earnings trajectory will determine whether elevated multiples prove justified.